Retatrutide

Retatrutide is a lipidated peptide of approximately 39 amino acids containing purposefully incorporated aminoisobutyric acid (Aib) and alpha-methyl-leucine. These non-natural residues affect conformational stability and accessibility to peptidases, both of which are relevant variables in controlled experiments.

A C20 fatty diacid is attached to a lysine side chain through a linker containing gamma-glutamate and AEEA units. This lipid anchor enables binding to serum albumin (Coskun et al. 2022; model type: preclinical). The structure therefore distinguishes retatrutide from a simple natural-peptide analogue: its receptor profile and persistence were engineered as separate molecular properties.

Source: Coskun et al. 2022, Cell Metabolism · PMID 35985340

GIPR, GLP-1R and GCGR are class B1 G-protein-coupled receptors. Although related, they differ enough in ligand recognition that a peptide will not ordinarily activate all three efficiently. “Triple agonist” describes exactly this binding and activation profile: one molecule acting at three target receptors. It does not establish an approved use or a guaranteed experimental outcome.

Structural basis: what cryo-EM shows

Cryo-EM structures of retatrutide bound to GLP-1R, GIPR and GCGR show the peptide adopting a continuous helix. Its N-terminal segment enters each receptor’s transmembrane core, while the C-terminal region binds the extracellular domain (Li et al. 2024; model type: in-vitro cryo-EM structural biology).

Retatrutide maintains contacts with conserved residues shared across the receptors while accommodating receptor-specific differences — particularly apparent in the first extracellular loop (ECL1), which forms a rigid alpha helix in GLP-1R and GCGR but a flexible loop in GIPR. For multi-target peptide research, these structures provide a defined model for investigating which contacts contribute to receptor selectivity.

Sources: Coskun 2022 · PMID 35985340 · Li 2024, Cell Discovery · PMID 39019866

The findings below describe outcomes in controlled clinical research. They do not establish an approved use, support self-experimentation or predict an outcome outside the cited studies.

Forums and community sources use several informal labels for the same substance, including “Triple G”, “GLP-3” and “Reta”. The triple g peptide, the glp-3 peptide and the reta peptide therefore all describe this one material. The correct substance name is Retatrutide, and its development code is LY3437943.

“GLP-3” is scientifically misleading because there is no GLP-3 receptor. In this context, the label refers to agonism at three established receptors: GIPR, GLP-1R and GCGR (Li et al. 2024). These terms are clarified here but are not used as product names.

Source: Li et al. 2024, Cell Discovery · PMID 39019866

This retatrutide research peptide is supplied as 10 mg of lyophilised material. Batch details and the corresponding analytical documentation appear in the product data and applicable certificate of analysis (COA).

Storage and laboratory handling: Lyophilised peptides are stored dry, protected from light and refrigerated. Temperature cycling and moisture ingress are significant practical quality risks. Before a container is opened in the laboratory, it should be allowed to reach room temperature to reduce condensation inside it (Wang 2000; review of the stability and storage of lyophilised peptide preparations).

Batch documentation: Purity information is always batch-specific and is communicated only with the linked COA. This page makes no blanket purity claim.

Source: Wang 2000, Int. J. Pharmaceutics · PMID 10967427

Reborn lists retatrutide exclusively as a laboratory research material for laboratories and researchers across the EU. Seven PubMed-indexed sources — spanning The New England Journal of Medicine, The Lancet, Nature Medicine, Cell Metabolism and Cell Discovery — document the research landscape from preclinical work through phase 1b and phase 2, and every scientific claim in this section is tied to one of them.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.